The presence of CD38 in CLL is associated with a worse survival prognosis, as well as an increase of CD38 expression on tumor cells, which reflects a switch to a more aggressive CLL type [41]. This evidence concerns the gene CD38 and B-cell chronic lymphocytic leukemia.